Erratum: Chondroitin Sulfate and Hyaluronic Acid Perfusion for Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Paper link corrected: https://bonoi.org/index.php/si/article/view/636
It has been brought to authors attention that there is a missing part in “Materials and Methods” of the Systematic Review article by Xiao et al., entitled “Chondroitin Sulfate and Hyaluronic Acid Perfusion for Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis” in the Volume 39, No. 4 of Science Insights (pp.363-373).
The missing part of the “Materials and Methods” is as below:
Population: Patients with IC/BPS.
Intervention: All patients underwent intravesical HA and/or CS treatment regimen.
Comparison: Improvement in symptoms pre-treatment and post-treatment or other treatment regimen.
Outcome: The primary outcome was the change in visual analogue scale (VAS) for pain symptom from baseline to the follow-up period; secondary outcomes were the changes in total scores of the O’Leary-Sant Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI), storage symptoms including frequency and urgency, and bladder capacity.
##plugins.themes.bootstrap3.article.details##
This work was funded by the National Natural Science Foundation of China (#81872567).

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.